A proposed bill in Tennessee aims to restrict the actions of Pharmacy Benefits Managers (PBMs), sparking a debate over the future of pharmacy services in the state. The bill, filed by Senator Bobby Harshbarger, seeks to prevent PBMs from owning or operating retail or mail-order pharmacies, effectively banning them from holding pharmacy licenses. This move comes as a response to the perceived issues caused by PBMs within the state's pharmaceutical landscape.
But here's where it gets controversial: CVS Pharmacy, a prominent PBM, has threatened to close its 134 pharmacies in Tennessee if the bill is passed. This has raised concerns among independent pharmacists and patients alike. CVS representatives argue that the bill would lead to pharmacy closures, including their 25 Minute Clinics, which provide retail medical services. However, Senator Harshbarger, a pharmacist himself, refutes this claim.
He emphasizes that the bill does not mandate any closures and that any potential closures would be business decisions made by PBMs, not a direct result of the legislation. Harshbarger highlights the potential for divestment rather than closure, suggesting that the ecosystem in Tennessee can absorb and transfer patients if necessary. This perspective challenges the fear-mongering tactics employed by the PBM industry in other states, where similar bills have been met with resistance.
The controversy surrounding this bill underscores the complex relationship between PBMs, insurance companies, and pharmacies. While PBMs aim to manage prescription drug benefits and lower costs, they have faced criticism for contributing to high drug prices and low reimbursements for independent pharmacists. The proposed bill in Tennessee seeks to address these concerns, but it also invites a discussion on the balance between PBM oversight and the continuity of pharmacy services for patients.
